NasdaqCM - Nasdaq Real Time Price • USD
Tenax Therapeutics, Inc. (TENX)
As of 11:36 AM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | -2.4 | -1.64 | -7.42 | -3.63 |
Low Estimate | -3.06 | -2.2 | -8.14 | -5.32 |
High Estimate | -1.74 | -1.09 | -6.71 | -1.94 |
Year Ago EPS | -12 | -4 | -31.04 | -7.42 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -29.6 | -8 | -7.2 | -8.14 |
EPS Actual | -12 | -4 | -6.4 | -12.98 |
Difference | 17.6 | 4 | 0.8 | -4.84 |
Surprise % | 59.50% | 50.00% | 11.10% | -59.50% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -2.4 | -1.64 | -7.42 | -3.63 |
7 Days Ago | -2.4 | -1.64 | -7.42 | -3.63 |
30 Days Ago | -1.86 | -1.26 | -6.33 | -3.28 |
60 Days Ago | -1.86 | -1.26 | -6.33 | -3.28 |
90 Days Ago | -7.2 | -8 | -30 | -27.7 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | TENX | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 80.00% | -- | -- | 1.50% |
Next Qtr. | 59.00% | -- | -- | 11.40% |
Current Year | 76.10% | -- | -- | 5.20% |
Next Year | 51.10% | -- | -- | 13.40% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | Roth MKM: Buy to Buy | 2/20/2024 |
Related Tickers
REVB Revelation Biosciences, Inc.
2.1600
+3.35%
EYEN Eyenovia, Inc.
0.7100
+21.68%
PXMD PaxMedica, Inc.
0.7048
+1.85%
BPTH Bio-Path Holdings, Inc.
2.5899
+3.60%
BNTC Benitec Biopharma Inc.
6.67
-0.82%
ENSC Ensysce Biosciences, Inc.
0.5551
-0.63%
PALI Palisade Bio, Inc.
6.07
-4.41%
SEEL Seelos Therapeutics, Inc.
0.2813
-6.55%
TCON TRACON Pharmaceuticals, Inc.
1.9200
+1.59%
CHRO Chromocell Therapeutics Corporation
1.5200
-3.18%